Evidence map›Paper›PMID 35545349›Full record

ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2022

Primary lung adenocarcinoma complicated with lung hamartoma: A case report and literature review.

Li Wang, Liang Zhou, Jianyong Zhang

Open access · greenAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Li WangDepartment of Pulmonary and Critical Care Medicine, Affliated Hospital of Zunyi Medical University, Zunyi Guizhou 563000, China. 306528927@qq.com.
Liang ZhouDepartment of Pulmonary and Critical Care Medicine, Affliated Hospital of Zunyi Medical University, Zunyi Guizhou 563000, China.
Jianyong ZhangDepartment of Pulmonary and Critical Care Medicine, Affliated Hospital of Zunyi Medical University, Zunyi Guizhou 563000, China. zjy9453@sina.com.
Zunyi Medical University · CN

Funding

the Science and Technology Plan Project of Guizhou Province, China [2020]4Y162
6 · The paper itself

Abstract

The clinical data for a patient with primary lung adenocarcinoma complicated with pulmonary hamartoma, who admitted to Zunyi Medical University Hospital in September 2020, was retrospectively analyzed. The 62-years-old male visited outpatient service because of dysphagia in March 2015, and the pulmonary nodules were found. In September 2020, the computed tomography indicated the enlarged nodule in the lower lobe of left lung with lobulation, and there was ground glass nodule in the upper lobe of left lung. After thoracoscopic wedge surgery, the primary pulmonary adenocarcinoma in the upper lobe of left lung and pulmonary hamartoma in the lower lobe of left lung were confirmed by pathology. Whole exon sequencing revealed that kinesin family member 20B (

Indexed as

Adenocarcinoma of LungHamartomaLung NeoplasmsHumansKinesinsLungMaleMiddle AgedRetrospective StudiesKIF20B protein, humanKinesinshamartoma of the lungimageologyprimary lung adenocarcinoma

Identifiers

PMID35545349
PMCPMC10930155
OpenAlexW4280520898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.